Representativeness of the dabigatran, apixaban and rivaroxaban clinical trial populations to real-world atrial fibrillation patients in the United Kingdom: a cross-sectional analysis using the General Practice Research Database

Representativeness of the dabigatran, apixaban and rivaroxaban clinical trial populations to real-world atrial fibrillation patients in the United Kingdom: a cross-sectional analysis using the General Practice Research Database

Objective Three oral anticoagulants have reported study results for stroke prevention in patients with atrial fibrillation (AF) (dabigatran etexilate, rivaroxaban and apixaban); all demonstrated superiority or non-inferiority compared with warfarin (RE-LY, ARISTOTLE and ROCKET-AF). This study aimed...

Full description

Saved in:
Bibliographic Details
Main Authors: Gregory Y H Lip, Sally Lee, Brigitta U Monz, Andreas Clemens, Martina Brueckmann
Format: Article
Language:English
Published: BMJ Publishing Group 2012-12-01
Series:BMJ Open
Online Access:https://bmjopen.bmj.com/content/2/6/e001768.full
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items